4.7 Review

Antibiotics, gut microbiota, environment in early life and type 1 diabetes

Journal

PHARMACOLOGICAL RESEARCH
Volume 119, Issue -, Pages 219-226

Publisher

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2017.01.034

Keywords

Gut microbiota; Neonatal immune response; Type 1 diabetes; Immune regulation

Funding

  1. NIH [DK092882, DK100500, P30 DK945735]
  2. American Diabetes Association [14-13-BS-222]
  3. JDRF [2015-136]

Ask authors/readers for more resources

The gut microbiota interact with innate immune cells and play an important role in shaping the immune system. Many factors may influence the composition of the microbiota such as mode of birth, diet, infections and medication including antibiotics. In diseases with a multifactorial etiology, like type 1 diabetes, manipulation and alterations of the microbiota in animal models have been shown to influence the incidence and onset of disease. The microbiota are an important part of the internal environment and understanding how these bacteria interact with the innate immune cells to generate immune tolerance may open up opportunities for development of new therapeutic strategies. In this review, we discuss recent findings in relation to the microbiota, particularly in the context of type 1 diabetes. (C) 2017 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available